Natera Inc.

(NTRA) Trade

By |

Profile

Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing genetic features of a fetus. Natera's array of diagnostic services include Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic or a patient for the test upon delivery of the test result.

Contact Information

Website: www.natera.com
Email: investor_relations@manulife.com
Main Phone: +1 650 249-9090
Address: 201 Industrial Road
Address 2: Suite 410
State: CA
City / Town: San Carlos
Country: USA
Postal Code: 94070

Issuer Information

Exchange: NGS
CEO: Steven Leonard Chapman
Employees: 975
NAICS: Medical Laboratories(621511)

Equities News

Profile

Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing genetic features of a fetus. Natera's array of diagnostic services include Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic or a patient for the test upon delivery of the test result.

Contact Information

Website: www.natera.com
Email: investor_relations@manulife.com
Main Phone: +1 650 249-9090
Address: 201 Industrial Road
Address 2: Suite 410
State: CA
City / Town: San Carlos
Country: USA
Postal Code: 94070

Issuer Information

Exchange: NGS
CEO: Steven Leonard Chapman
Employees: 975
NAICS: Medical Laboratories(621511)

Equities News

$ 35.17 $ -1.99 (-5.36%)
Last Price 35.17 Change $ -1.99 Change % -5.36 Tick N/A
Bid 35.01 Bid Size 100.00 Ask 37.90 Ask Size 100.00
Open 37.04 High 37.33 Low 34.92 Prev Close 37.16
Last Trade Volume 914,634 52 Wk Hi 40.92 52 Wk Low 11.08
Market Cap 2.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 77,528,812.00 EPS (TTM) -1.86 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 17 22
Number of Buys 8 11
Number of Sells 9 11
Net Activity -324539 -441006
Last 10 Buys Shares
Roelof Frederik Botha 1,000
Roelof Frederik Botha 1,000
John Steuart 1,000
John Steuart 1,000
James I. Healy 1,000
James I. Healy 1,000
James I. Healy 1,000
James I. Healy 1,000
Last 10 Sell Shares
Randall Hawks 1,000
Randall Hawks 1,000
Randall Hawks 1,000
Randall Hawks 1,000
Jonathan Sheena 1,000
Michael Brophy 1,000
Steven Leonard Chapman 1,000
Jonathan Sheena 1,000
Jonathan Sheena 1,000
Herm Rosenman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 18 18 18 18
Low Target Price Estimate 12 12 12 12
Mean Target Price Estimate 16.17 16.17 16.17 16.17
Standard Deviation 2.23 2.23 2.23 2.23
Date of Most Recent Estimate 05/15/18 05/15/18 05/09/18 06/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 4
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.08 1.08 1.08 1.1